Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00865566
What this trial is testing

Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 2,504
Not applicableStudy completedNCT07444502
What this trial is testing

Safety Monitoring of Boostagen® Vaccine in Thailand

Who this might be right for
Pertussis (Whooping Cough)TetanusDiphtheria
BioNet-Asia Co., Ltd. 10,727
Post-approval studies (Phase 4)Study completedNCT05512494
What this trial is testing

Lot-to-lot Consistency of Quadrivalent Influenza Vaccine (Split Virion), Inactivated

Who this might be right for
Seasonal Influenza
Sinovac Biotech Co., Ltd 1,260
Early research (Phase 1)UnknownNCT05433194
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19 Omicron) mRNA Vaccine (Phase 1)

Who this might be right for
COVID-19
Suzhou Abogen Biosciences Co., Ltd. 48
Testing effectiveness (Phase 2)Study completedNCT05197153
What this trial is testing

Evaluate the Safety and Immunogenicity of Booster With AZD1222, mRNA-1273, or MVC-COV1901 Against COVID-19

Who this might be right for
COVID-19 Vaccine
Medigen Vaccine Biologics Corp. 804
Early research (Phase 1)Study completedNCT00002353
What this trial is testing

A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects

Who this might be right for
HIV Infections
United Biomedical
Post-approval studies (Phase 4)Study completedNCT03274102
What this trial is testing

Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI Vaccines

Who this might be right for
Hand, Foot and Mouth Disease
Sinovac Biotech Co., Ltd 780
Not applicableUnknownNCT05208983
What this trial is testing

SafeTy and Efficacy of Preventative CoVID Vaccines

Who this might be right for
COVID-19 Virus InfectionVaccine Response
University Health Network, Toronto 1,286
Large-scale testing (Phase 3)Study completedNCT00291941
What this trial is testing

Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.

Who this might be right for
Hepatitis B
Henogen 300
Testing effectiveness (Phase 2)Study completedNCT03902054
What this trial is testing

Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine.

Who this might be right for
Polio and Post-Polio Syndrome
Jiangsu Province Centers for Disease Control and Prevention 600
Early research (Phase 1)Study completedNCT01972737
What this trial is testing

Phase I Study of Ad5-hGCC (Human Guanylyl Cyclase C)-PADRE in Stage I/II Colon Cancer

Who this might be right for
Colon Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 10
Testing effectiveness (Phase 2)Study completedNCT02956837
What this trial is testing

Rank Different Dosages of Antigen of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A), Based on Their Immune Response and Safety, When Administered to Healthy Adult Women

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 406
Early research (Phase 1)WithdrawnNCT05609045
What this trial is testing

A Phase 1, Randomised, Double-blinded, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Immunogenicity of RH109 as Booster

Who this might be right for
COVID-19 Pandemic
Wuhan Rhegen Biotechnology Co., Ltd.
Early research (Phase 1)Study completedNCT02401373
What this trial is testing

A Phase I Trial to Evaluate Ad5-EBOV in Healthy Adult Africans in China.

Who this might be right for
Ebola Virus Disease
First Affiliated Hospital of Zhejiang University 61
Testing effectiveness (Phase 2)Study completedNCT02538341
What this trial is testing

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)

Who this might be right for
Rheumatoid ArthritisInflammatory ArthritisArthritis+5 more
University of Alabama at Birmingham 617
Large-scale testing (Phase 3)Study completedNCT01418937
What this trial is testing

Safety Evaluation of a Human Papillomavirus (HPV) Vaccine in Healthy Female Control Subjects From the GSK HPV 023 Study

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 164
Early research (Phase 1)Ended earlyNCT05701800
What this trial is testing

Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of Age

Who this might be right for
Herpes Zoster
ModernaTX, Inc. 659
Testing effectiveness (Phase 2)Study completedNCT01258595
What this trial is testing

High-Dose Trivalent Inactivated Influenza Vaccine in Adults 50 to 64 Years of Age

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 300
Early research (Phase 1)Study completedNCT01250795
What this trial is testing

Safety and Immunogenicity Of A Recombinant H5N1 Vaccine In Adults

Who this might be right for
Healthy
Fraunhofer, Center for Molecular Biotechnology 100
Post-approval studies (Phase 4)Study completedNCT04997239
What this trial is testing

A Clinical Trial of Quadrivalent Influenza Vaccine in Children Aged 3-8 Years Old

Who this might be right for
Seasonal Influenza
Sinovac Biotech Co., Ltd 600
Next Page